Quantbot Technologies’s TherapeuticsMD TXMD Stock Holding History

Quantbot Technologies’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-64	Closed	-$1K	–	2144
2022 Q1	$1K	Hold	64	–	–	﹤0.01%	1586
2021 Q4	$1K	Hold	64	–	–	﹤0.01%	1432
2021 Q3	$2K	Sell	64 -226	-78%	-$10K	﹤0.01%	1441
2021 Q2	$17K	Sell	290 -748	-72%	-$45.3K	﹤0.01%	1242
2021 Q1	$69K	Buy	+1,038	New	+$81.3K	0.01%	949
2020 Q3	–	Sell	-112	Closed	-$7K	–	1651
2020 Q2	$7K	Buy	+112	New	+$6.52K	﹤0.01%	974
2019 Q2	–	Sell	-383	Closed	-$93K	–	1443
2019 Q1	$93K	Buy	+383	New	+$101K	0.01%	780
2018 Q3	–	Sell	-421	Closed	-$131K	–	1557
2018 Q2	$131K	Buy	421 +253	+151%	+$77.3K	0.01%	827
2018 Q1	$40K	Buy	+168	New	+$47.1K	﹤0.01%	998
2017 Q4	–	Sell	-716	Closed	-$189K	–	1493
2017 Q3	$189K	Buy	+716	New	+$207K	0.02%	722
2017 Q2	–	Sell	-36	Closed	-$12K	–	1396
2017 Q1	$12K	Buy	+36	New	+$11.1K	﹤0.01%	1041

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Quantbot Technologies's TXMD Position: Q2 2022 in Review

Quantbot Technologies sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 64 shares — an estimated $1K sold.

Quantbot Technologies first reported a position in TXMD in Q1 2017 and held it in 11 quarters. The position peaked at $189K in Q3 2017. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

Quantbot Technologies reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
Quantbot Technologies sold 64 TherapeuticsMD shares in Q2 2022, an estimated $1K.
Quantbot Technologies first reported a position in TherapeuticsMD in Q1 2017 and held it in 11 quarters.
Quantbot Technologies's TherapeuticsMD position peaked at $189K in Q3 2017.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.